NIH Seeks Approval to Keep Tracking Clinical Trial Data
Published Date: 2/19/2026
Notice
Summary
The National Institutes of Health (NIH) is asking for a 30-day public comment on their plan to keep and update a big list of clinical trials and their results. This affects researchers and medical folks who share trial info, helping everyone find trustworthy health study data. No big costs or changes are expected, but your feedback is welcome before the current approval expires on March 31, 2026.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
NIH Seeks 3-Year OMB Clearance
The NIH is asking OMB to approve the ClinicalTrials.gov information collection (OMB control number 0925-0586) for 3 years. The current approval expires on 03/31/2026, and the agency estimates total annualized respondent burden of 1,411,181 hours and says there are no costs to respondents other than their time.
Mandatory Registration and Results Rule Applies
The notice restates that 42 CFR part 11 requires registration and results submission for certain applicable clinical trials of drug, biological, and device products, whether or not the products are FDA approved, licensed, or cleared. Entities running those trials must register and submit results as required by the regulation.
Continued Public Access to Trial Data
NIH operates ClinicalTrials.gov to collect registration and results information to enhance patient enrollment and to track study progress for the benefit of public health. The registry is widely used by patients, physicians, and medical researchers and will continue to be maintained.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2026-03221 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late March 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for brain, cancer, and cell biology studies. Scientists and researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Next: 2026-03223 — Notice of Inventory Completion: University of Florida, Florida Museum of Natural History, Gainesville, FL
The University of Florida’s Florida Museum of Natural History has finished checking its collection of Native American human remains and related items from 24 Florida sites. They found 416 individuals and nearly 22,000 objects connected to Native tribes. Starting March 23, 2026, these remains and items can be returned to the tribes, making history and healing happen!
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in